Pi Ventures

Pi Ventures is one of India’s most distinctive deep-tech and applied-AI funds, headquartered in Bengaluru and explicitly built around frontier technology bets including AI/ML, computer vision, and emerging modalities like nanorobotics and computational diagnostics. The firm has built a recognisable healthcare portfolio anchored by SigTuple in AI-driven pathology and Niramai in thermal-imaging breast cancer screening, with cheques typically in the $1M-$5M range at Seed and Series A. Pi is one of the few Indian funds with the technical bench to underwrite genuinely deep AI and medtech bets rather than thin-wrapper consumer plays. The right founder is a technical founder, often with a PhD or strong research pedigree, building a defensible AI or hardware-enabled healthcare product with regulatory pathway clarity and a real data moat. Founders building me-too telehealth, asset-heavy clinic chains, or hype-driven generative AI applications without clinical evidence should not approach. The cleanest entry path is via Manish Singhal or Roopan Aulakh directly, an IISc or IIT-Bombay alumni introduction, or a Pi portfolio CEO. In the pitch, lead with technical depth, IP strategy, regulatory positioning (CDSCO, FDA, CE), and a credible plan for clinical validation and adoption; commercial traction matters but is secondary to defensibility. Caveats: Pi runs a concentrated portfolio with high reserves per company, but cycle times can be long given the technical diligence required. The firm’s brand carries strong signal in India and growing weight internationally, but founders should plan for international co-leads as they scale into Series B and beyond. Confirm fund vintage and current cheque sizing, since Pi has raised multiple funds with evolving thesis emphasis between AI and frontier hardware.